Biotechnology - Biotechnology, Chelsea Therapeutics

Filter

Popular Filters

FDA approves Northera for neurogenic orthostatic hypotension

FDA approves Northera for neurogenic orthostatic hypotension

19-02-2014

Shares of US biotech firm Chelsea Therapeutics soared 38% to $6.75 in after-hours trading yesterday,…

BiotechnologyChelsea TherapeuticsDainippon Sumitomo PharmaNorth AmericaNortheraRare diseasesRegulationUSA

Chelsea Therapeutics names Joseph Oliveto as president and CEO

Chelsea Therapeutics names Joseph Oliveto as president and CEO

27-01-2014

US biotech firm Chelsea Therapeutics’ (Nasdaq: CHTP) has named Joseph Oliveto as president and chief…

BiotechnologyBoardroomChelsea TherapeuticsUSA

Surprise FDA advisory panel backing for Chelsea’s Northera

Surprise FDA advisory panel backing for Chelsea’s Northera

15-01-2014

A US Food and Drug Administration advisory panel has voted 16-one to recommend approval of US biotech…

BiotechnologyCardio-vascularChelsea TherapeuticsNorth AmericaNortheraRegulationUSA

US FDA further delays Chelsea's Northera

29-07-2013

US biotech firm Chelsea Therapeutics (Nasdaq: CHTP) has received acknowledgment of its resubmitted New…

BiotechnologyCardio-vascularChelsea TherapeuticsNorth AmericaNortheraRegulation

Chelsea Thera to re-file Northera NDA with existing data; Celgene share buyback

21-02-2013

Chelsea Therapeutics International (Nasdaq: CHTP) saw its shares more than double to $1.61 in pre-market…

BiotechnologyCardio-vascularCelgeneChelsea TherapeuticsFinancialNorth AmericaNortheraRegulation

Chelsea Therapeutics and Savient to slash jobs

11-07-2012

Chelsea Therapeutics International (Nasdaq: CHTP) yesterday announced restructuring plans to "significantly…

BiotechnologyChelsea TherapeuticsFinancialKrystexxaManagementNortheraSavient Pharmaceuticals

Chelsea Thera gets disappointing news from FDA on Northera

04-07-2012

US biotech firm Chelsea Therapeutics International (Nasdaq: CHTP) shares tumbled in pre-market trading…

BiotechnologyCardio-vascularChelsea TherapeuticsNorth AmericaNortheraRare diseasesRegulation

FDA calls for more data from Chelsea Thera on Northera

30-03-2012

The US Food and Drug Administration has issued a complete response letter regarding the New Drug Application…

BiotechnologyChelsea TherapeuticsNeurologicalNorth AmericaNortheraRegulation

FDA panels back Forest and Almirall COPD drug and Chelsea’s Northera for NOH

24-02-2012

The US Food and Drug Administration’s Pulmonary-Allergy Drugs Advisory Committee (PADAC) voted 12…

aclidiniumAlmirallBiotechnologyChelsea TherapeuticsEkliraForest LaboratoriesNeurologicalNorth AmericaNortheraPharmaceuticalRegulationRespiratory and PulmonaryTudorza Pressair

Company Spotlight

ImmunoGen

ImmunoGen

Back to top